Ionis Pharmaceuticals Income Statement (2009-2026) | IONS

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026
Revenue & cost
Revenue (Quarter)	133.09M	440.01M	141.92M	133.79M	159.77M	151.89M	130.52M	188.41M	144.21M	324.50M	119.50M	225.25M	133.81M	226.58M	131.61M	452.05M	156.72M	203.33M	50.00M	267.95M
Cost of Revenue (Quarter)	3.08M	2.23M	4.17M	4.75M	1.51M	3.69M	1.34M	2.54M	2.19M	3.06M	2.15M	4.16M	1.07M	3.83M	1.46M	4.15M	2.34M	7.96M	2.98M	2.74M
Gross Profit (Quarter)	130.01M	437.78M	137.75M	129.05M	158.25M	148.20M	129.18M	185.87M	142.02M	321.44M	117.35M	221.09M	132.74M	222.75M	130.15M	447.90M	154.38M	195.37M	47.02M	265.21M
Operating items
Research & Development (Quarter)	184.77M	-429.08M	161.13M	180.76M	182.99M	-444.88M	197.81M	229.93M	215.33M	256.56M	214.22M	222.06M	219.76M	245.49M	200.76M	217.46M	217.75M	279.65M	210.17M	217.11M
Selling, General & Administrative (Quarter)	31.09M	37.60M	34.13M	33.80M	34.42M	47.95M	45.52M	46.14M	69.95M	71.01M	52.64M	65.11M	61.64M	88.08M	76.25M	90.62M	96.81M	130.19M	150.36M	150.40M
Other Operating Expenses (Quarter)	3.08M	610.88M	4.17M	4.75M	1.51M	756.83M	1.34M	2.54M	2.19M	3.06M	2.15M	4.16M	1.07M	3.83M	1.46M	4.15M	2.34M	7.96M	2.98M	2.74M
Operating Expenses (Quarter)	218.94M	219.40M	199.42M	219.31M	218.92M	359.91M	244.67M	278.61M	287.47M	330.63M	269.01M	291.34M	282.47M	337.40M	278.47M	312.23M	316.90M	417.79M	363.51M	370.24M
Operating Income (Quarter)	-85.85M	220.60M	-57.50M	-85.51M	-59.15M	-208.02M	-114.15M	-90.19M	-143.26M	-6.12M	-149.51M	-66.09M	-148.66M	-110.82M	-146.86M	139.82M	-160.18M	-214.46M	-117.42M	-102.29M
EBIT (Quarter)	-85.85M	220.60M	-57.50M	-85.51M	-59.15M	-208.02M	-114.15M	-90.19M	-143.26M	-6.12M	-149.51M	-66.09M	-148.66M	-110.82M	-146.86M	139.82M	-160.18M	-214.46M	-117.42M	-102.29M
Non-operating items
Non Operating Investment Income (Quarter)	4.01M	5.22M	-6.62M	-6.34M	2.35M	3.28M	-0.53M	0.72M	-1.94M	-0.16M	2.33M	-3.53M	0.88M	-2.57M	-2.16M	-18.31M	29.91M	0.79M	22.58M	-10.18M
Interest & Investment Income (Quarter)	0.87M	1.81M	1.99M	3.40M	7.52M	11.88M	18.63M	20.79M	23.93M	25.69M	26.29M	25.60M	26.23M	28.91M	24.67M	24.69M	23.68M	24.73M	25.48M	20.23M
Other Non Operating Income (Quarter)	-0.47M	32.48M	0.19M	-12.30M	4.71M	47.65M	0.23M	11.18M	2.45M	53.27M	0.28M	0.61M	0.14M	52.47M	0.47M	0.10M	0.36M	18.34M	-0.46M	0.99M
Net income details
EBT (Quarter)	-83.77M	224.10M	-64.07M	-102.88M	-46.71M	-44.84M	-112.94M	-77.45M	-140.81M	-3.51M	-142.73M	-66.20M	-144.10M	-107.68M	-146.82M	123.53M	-128.39M	-229.50M	-92.31M	-113.38M
Tax Provisions (Quarter)	-1.31M	13.74M	1.10M	2.30M	0.30M	-57.81M	11.40M	7.84M	6.60M	-95.96M	0.10M	0.06M	-3.62M	-93.11M	0.12M	-0.02M	0.21M	-80.02M	0.22M	1.26M
Profit After Tax (Quarter)	-82.47M	224.61M	-65.17M	-105.14M	-46.99M	-52.43M	-124.32M	-85.29M	-147.41M	-9.26M	-142.80M	-66.27M	-140.48M	-104.35M	-146.94M	123.55M	-128.61M	-229.39M	-92.53M	-114.65M
Income from Non-Controlling Interests (Quarter)		0.50M
Income from Continuing Operations (Quarter)	-82.47M	210.36M	-65.17M	-105.17M	-47.01M	12.98M	-124.34M	-85.29M	-147.41M	92.45M	-142.83M	-66.27M	-140.48M	-14.57M	-146.94M	123.55M	-128.61M	-149.47M	-92.53M	-114.65M
Consolidated Net Income (Quarter)	-82.47M	210.36M	-65.17M	-105.17M	-47.01M	12.98M	-124.34M	-85.29M	-147.41M	92.45M	-142.83M	-66.27M	-140.48M	-14.57M	-146.94M	123.55M	-128.61M	-149.47M	-92.53M	-114.65M
Income towards Parent Company (Quarter)	-82.47M	210.36M	-65.17M	-105.17M	-47.01M	12.98M	-124.34M	-85.29M	-147.41M	92.45M	-142.83M	-66.27M	-140.48M	-14.57M	-146.94M	123.55M	-128.61M	-149.47M	-92.53M	-114.65M
Net Income towards Common Stockholders (Quarter)	-82.47M	210.36M	-65.17M	-105.17M	-47.01M	12.98M	-124.34M	-85.29M	-147.41M	92.45M	-142.83M	-66.27M	-140.48M	-14.57M	-146.94M	123.55M	-128.61M	123.55M	-92.53M	-114.65M
Additional items
EPS (Basic) (Quarter)	-0.58	1.49	-0.46	-0.74	-0.33	0.09	-0.87	-0.60	-1.03	0.65	-0.98	-0.45	-0.95	-0.10	-0.93	0.78	-0.80	0.77	-0.56	-0.69
EPS (Diluted) (Quarter)	-0.58	1.49	-0.46	-0.74	-0.33	0.09	-0.87	-0.60	-1.03	0.65	-0.98	-0.45	-0.95	-0.10	-0.93	0.68	-0.80	0.77	-0.56	-0.69
Shares Outstanding (Quarter)	141.14M	141.02M	141.60M	141.79M	141.95M	141.85M	142.74M	143.10M	143.32M	143.19M	145.54M	145.96M	148.59M	149.51M	158.74M	159.14M	159.76M	160.01M	164.87M	165.42M
Shares Outstanding (Diluted) (Quarter)	141.14M	141.02M	141.60M	141.79M	141.95M	141.85M	142.74M	143.10M	143.32M	143.19M	145.54M	145.96M	148.59M	149.51M	158.74M	182.33M	159.76M	160.01M	164.87M	165.42M
Shares Outstanding (Entity) (Quarter)	141.18M	141.21M	141.75M	141.83M	142.02M	142.06M	143.02M	143.17M	143.39M	144.34M	145.84M	146.03M	157.81M	157.91M	159.04M	159.20M	161.14M	163.30M	165.90M	165.64M
EBITDA (Quarter)	-85.85M	220.60M	-57.50M	-85.51M	-59.15M	-208.02M	-114.15M	-90.19M	-143.26M	-6.12M	-149.51M	-66.09M	-148.66M	-110.82M	-146.86M	139.82M	-160.18M	-214.46M	-117.42M	-102.29M
Interest Expenses (Quarter)	14.20M	5.82M	19.03M	23.93M	32.63M	5.92M	20.31M	21.28M	16.27M	-1.59M	12.00M	11.40M	10.70M	5.16M	9.30M	8.60M	230.00M	5.38M	17.60M	16.60M
Tax Rate (Quarter)	1.56%	6.13%	-1.72%	-2.24%	-0.64%	128.94%	-10.09%	-10.13%	-4.69%	2,734.63%	-0.07%	-0.10%	2.51%	86.47%	-0.08%	-0.02%	-0.17%	34.87%	-0.24%	-1.11%

Research Tools

Datasets

Plans

Developers

Ionis Pharmaceuticals Income Statement (2009-2026) | IONS

Research Tools

Datasets

Plans

Developers

Ionis Pharmaceuticals Income Statement (2009-2026) | IONS

Create an account

Sign In

Reset Password